Location History:
- Pessac, FR (2020)
- Le Plessis Robinson, FR (2020 - 2024)
Company Filing History:
5 out of 1,743 
4 out of 5,069 
4 out of 316 
Years Active: 2020-2025
Title: Gilles Bru-Mercier: Innovator in NMDA Receptor Antagonists
Introduction
Gilles Bru-Mercier is a notable inventor based in Le Plessis-Robinson, France. He has made significant contributions to the field of pharmacology, particularly in the development of NMDA receptor antagonists. With a total of 5 patents to his name, Bru-Mercier's work has implications for various therapeutic applications.
Latest Patents
Among his latest patents, Bru-Mercier has focused on dizocilpine derivatives as peripheral NMDA receptor antagonists. The present invention relates to compounds of formula (I) for use as peripheral NMDA receptor antagonists. This innovative approach aims to enhance the efficacy of treatments targeting neurological disorders.
Career Highlights
Throughout his career, Gilles Bru-Mercier has worked with prestigious institutions such as the Institut National de la Santé et de la Recherche Médicale and the Centre National de la Recherche Scientifique. His experience in these organizations has allowed him to advance his research and contribute to the scientific community.
Collaborations
Some of his notable coworkers include Sylvia Cohen-Kaminsky and Marc Humbert. Their collaborative efforts have further enriched the research landscape in which Bru-Mercier operates.
Conclusion
Gilles Bru-Mercier stands out as an influential inventor in the realm of NMDA receptor antagonists. His innovative patents and collaborations reflect his commitment to advancing medical science.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.